DK0414007T3 - Hidtil ukendt arginindeiminase, dens fremstillingsmetode og et anti-cancermiddel indeholdende dette enzym som en effektiv ingrediens - Google Patents

Hidtil ukendt arginindeiminase, dens fremstillingsmetode og et anti-cancermiddel indeholdende dette enzym som en effektiv ingrediens

Info

Publication number
DK0414007T3
DK0414007T3 DK90114846.0T DK90114846T DK0414007T3 DK 0414007 T3 DK0414007 T3 DK 0414007T3 DK 90114846 T DK90114846 T DK 90114846T DK 0414007 T3 DK0414007 T3 DK 0414007T3
Authority
DK
Denmark
Prior art keywords
enzyme
cancer agent
preparation
agent containing
arginine deiminase
Prior art date
Application number
DK90114846.0T
Other languages
English (en)
Inventor
Haruo Takaku
Kaoru Miyazaki
Miho Aoshima
Original Assignee
Japan Energy Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Japan Energy Corp filed Critical Japan Energy Corp
Application granted granted Critical
Publication of DK0414007T3 publication Critical patent/DK0414007T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/78Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK90114846.0T 1989-08-02 1990-08-02 Hidtil ukendt arginindeiminase, dens fremstillingsmetode og et anti-cancermiddel indeholdende dette enzym som en effektiv ingrediens DK0414007T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP20090289 1989-08-02

Publications (1)

Publication Number Publication Date
DK0414007T3 true DK0414007T3 (da) 1995-09-04

Family

ID=16432163

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90114846.0T DK0414007T3 (da) 1989-08-02 1990-08-02 Hidtil ukendt arginindeiminase, dens fremstillingsmetode og et anti-cancermiddel indeholdende dette enzym som en effektiv ingrediens

Country Status (12)

Country Link
US (1) US5474928A (da)
EP (1) EP0414007B1 (da)
JP (1) JP2900279B2 (da)
AT (1) ATE125295T1 (da)
CA (1) CA2022177C (da)
DE (1) DE69020979T2 (da)
DK (1) DK0414007T3 (da)
ES (1) ES2078277T3 (da)
FI (1) FI903826A7 (da)
IE (1) IE62120B1 (da)
NO (1) NO178734C (da)
PT (1) PT94882B (da)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998024473A1 (fr) * 1996-12-03 1998-06-11 Kyowa Hakko Kogyo Co., Ltd. Inhibiteur de fibrose des tissus
US5804183A (en) * 1997-01-31 1998-09-08 Enzon, Inc. Arginine deminase derived from mycoplasma arthritidis and polymer conjugates containing the same
US6183738B1 (en) 1997-05-12 2001-02-06 Phoenix Pharamacologics, Inc. Modified arginine deiminase
US6635462B1 (en) * 1997-05-12 2003-10-21 Phoenix Pharmacologies, Inc. Mutated form of arginine deiminase
US6180387B1 (en) * 1997-08-11 2001-01-30 Smithkline Beecham Corporation Arginine deiminase
IT1298918B1 (it) * 1998-02-20 2000-02-07 Mendes Srl Uso di batteri dotati di arginina deiminasi per indurre apoptosi e/o ridurre una reazione infiammatoria e composizioni farmaceutiche
AU2001275810A1 (en) * 2000-07-27 2002-02-13 Angiolab, Inc. The pharmaceutical composition comprising arginine deiminase for inhibiting angiogenesis
CA2506244C (en) * 2002-11-18 2012-10-30 Phoenix Pharmacologics, Inc. Methods for inhibiting viral replication in vivo
FR2884717B1 (fr) 2005-04-25 2009-07-03 Erytech Pharma Soc Par Actions Erythrocytes renfermant de l'arginine deiminase
CN101002945B (zh) 2006-01-20 2012-09-05 清华大学 一种用于肿瘤治疗的新型复合物
FR2919804B1 (fr) 2007-08-08 2010-08-27 Erytech Pharma Composition et vaccin therapeutique anti-tumoral
EP2295560A1 (en) 2009-09-14 2011-03-16 RWTH Aachen University Directed evolution of arginine deiminase for increased activity at physiological pH
US9255262B2 (en) 2013-03-06 2016-02-09 Vision Global Holdings Ltd. Albumin-binding arginine deminase and the use thereof
USRE48805E1 (en) 2013-03-06 2021-11-02 Vision Global Holdings Ltd. Method for cancer targeting treatment and detection of arginine using albumin-binding arginine deiminase fusion protein
EP3744341A1 (en) 2013-03-15 2020-12-02 TDW Group Arginine deiminase with reduced cross-reactivity toward adi - peg 20 antibodies for cancer treatment
KR102523031B1 (ko) 2014-03-18 2023-04-19 티디더블유 그룹 조작된 키메라성 페길화된 adi 및 사용 방법
US11613759B2 (en) 2015-09-04 2023-03-28 Sqz Biotechnologies Company Intracellular delivery of biomolecules to cells comprising a cell wall
JP7602702B2 (ja) 2016-05-03 2024-12-19 ステムセル テクノロジーズ カナダ インコーポレーテッド 寛容性を誘導するための生体分子の細胞内送達
EP3534963B1 (en) 2016-11-02 2024-04-17 Polaris Group Formulations of pegylated arginine deiminase
EP3449935A1 (en) 2017-08-31 2019-03-06 Erytech Pharma Arginine deiminase encapsulated inside erythrocytes and their use in treating cancer and arginase-1 deficiency
WO2019042628A1 (en) 2017-08-31 2019-03-07 Erytech Pharma ARGININE DEIMINASE ENCAPSULATED WITHIN ERYTHROCYTES AND THEIR USE IN THE TREATMENT OF CANCER AND ARGINASE-1 DEFICIENCY

Also Published As

Publication number Publication date
EP0414007A2 (en) 1991-02-27
EP0414007A3 (en) 1991-03-20
NO903398L (no) 1991-02-04
PT94882B (pt) 1997-07-31
US5474928A (en) 1995-12-12
NO903398D0 (no) 1990-08-01
NO178734B (no) 1996-02-12
FI903826A0 (fi) 1990-08-01
ATE125295T1 (de) 1995-08-15
NO178734C (no) 1996-05-22
IE62120B1 (en) 1994-12-14
DE69020979T2 (de) 1996-01-04
EP0414007B1 (en) 1995-07-19
CA2022177C (en) 2001-02-27
CA2022177A1 (en) 1991-02-03
FI903826A7 (fi) 1991-02-03
IE902771A1 (en) 1991-02-27
JPH03164173A (ja) 1991-07-16
ES2078277T3 (es) 1995-12-16
DE69020979D1 (de) 1995-08-24
JP2900279B2 (ja) 1999-06-02
PT94882A (pt) 1991-05-22

Similar Documents

Publication Publication Date Title
DK0414007T3 (da) Hidtil ukendt arginindeiminase, dens fremstillingsmetode og et anti-cancermiddel indeholdende dette enzym som en effektiv ingrediens
BR9910251A (pt) Estimulação hematopoiética
UA26855C2 (uk) Фармацевтичhа композиція, яка регулює гематопоез
NZ240230A (en) Mercaptoacetylamide derivatives; preparation, use and pharmaceutical compositions thereof
EP0386757A3 (en) Biodegradable poly (phosphate esters)
FI873672A0 (fi) Kompositioner innehaollande l-3,4-dihydroxifenylalanin.
FI925787A0 (fi) Proteolytiska enzymers sackarinderivatinhibitorer
DK0506791T3 (da) Enzymholdigt præparat og detergent indeholdende et sådant præparat
AR240872A1 (es) Novedosas composiciones tensioactivas con base de esteres fosforicos de derivados polioxialquenados, su procedimiento de preparacion y su aplicacion a la formulacion de materias activas.
IT8920063A0 (it) Metodi per la preparazione di composizioni farmaceutiche a base di bromocriptina dotate di elevata stabilita' e prodotti derivanti.
IT1270618B (it) Proteine ad attivita' antitumorale
IT1216104B (it) Peptidi ad attivita' farmaceutica.
FI874996A0 (fi) Diamidien käyttö pehmennysaineena pesuainekoostumuksissa
DE59005128D1 (de) t-PA pro STABILISIERUNG.
IT8719093A0 (it) Derivati di esteri dell'acido immidazol-1-il-carbossilico, procedimenti per la loro preparazione e composizioni fungicide che contengono il derivato come componente attivo.
IT1213033B (it) Esteri di n-alchil-nortropine eloro derivati ammonioquaternari aventi attivita'anti-broncospastica, procedimento per la loro preparazione e composizioni farmaceutiche che licontengono.
IT1216103B (it) Peptidi ad attivita' farmaceutica.
PT82321A (en) Process for preparing insecticidal formulations comprising fluorinated cycloalkanecarboxanilides useful as diabrotica larvicidal agents
DE3863492D1 (de) Stabile 5-fluorouracil-formulierungen.
IT1197892B (it) Composizioni farmaceutiche ad attivita' cicatrizzante
UA26922C2 (uk) Похідhі сульфамідосульфоhілсечовиhи, що мають гербіцидhу активhість,та гербіцидhа композиція hа їх осhові
IT8847652A0 (it) Derivati della 2-ammino-6-7-dimetossi tetralina, procedimento per la loro preparazione e composizioni farmaceutiche ad attivita'antiipertensiva che le contengono.
IT8619478A0 (it) Esteri di cefem-derivati, loro preparazione e composizioni che licontengono.
IT8648751A0 (it) 1-n-propil-3-(2-metil-butil)-7-(5idrossiesil)-8-alchil-xantine ad attivita' antibroncospastica,composizioni farmaceutiche che le contengono e relativo procedimento per laloro preparazione
IT8422259A0 (it) Derivato del (-)-6,6-dimetilbiciclo [3.1.1] ept-2-ene-2-etanolo, ad attivita' mucosecretolitica, procedimento per la sua preparazione e composizioni farmaceutiche che lo contengono